[ Network menu | Network entry | Edit Network | Help ]

ENTRY	nt06521
Name	NLR signaling
Category	Pathway view; Immune system
Pathway	hsa04621 NOD-like receptor signaling pathway
Display	drug-target relation   disease type

N00940        IBD1     Blau syndrome N00941    Shigella N01112    Salmonella   N01567        NAIAD/VAMAS1   N00742        MWS/CINCA/FCAS1/DFNA34 N00743    IAV N00864    Yersinia N00933    Escherichia N00948    Shigella N01127    Salmonella N01126    Salmonella N00863    Yersinia N01568        IBD30     IBD19   N01569        FCAS2   N00867        FCAS4/AIFEC N00865    Yersinia N00949    Shigella   N00868        FMF/AFND N01570        PAPA N00866    Yersinia   N00934    N00935    Escherichia

IBD1	H01227	Inflammatory bowel disease (IBD)
Blau syndrome	H00285	Blau syndrome
Shigella	H00299	Shigellosis
Salmonella	H00113	Salmonellosis
NAIAD	H02588	NLRP1-associated autoinflammation with arthritis and dyskeratosis
VAMAS1	H01372	Vitiligo
MWS	H02555	Muckle-Wells syndrome
CINCA	H02556	CINCA syndrome
FCAS1	H02159	Familial cold autoinflammatory syndrome
DFNA34	H00604	Deafness, autosomal dominant
IAV	H00398	Influenza
Yersinia	H00297	Plague
	H00298	Yersiniosis
Escherichia	H00277	Enterohemorrhagic Escherichia coli (EHEC) infection
IBD30	H01227	Inflammatory bowel disease (IBD)
IBD19	H01227	Inflammatory bowel disease (IBD)
FCAS2	H02159	Familial cold autoinflammatory syndrome
FCAS4	H02159	Familial cold autoinflammatory syndrome
AIFEC	H01748	NLRC4 inflammasomopathy
FMF	H00288	Familial Mediterranean fever
AFND	H02590	Acute febrile neutrophilic dermatosis
PAPA	H00287	Pyogenic sterile arthritis, pyoderma gangrenosum, and acne syndrome